Document Detail

Therapies for scleroderma-related pulmonary arterial hypertension.
MedLine Citation:
PMID:  19885388     Owner:  NLM     Status:  Publisher    
Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, response to modern medical therapy has been disappointing in scleroderma-related PAH compared with other forms of PAH from the WHO group 1 classification of diseases, despite similar histological changes involving the pulmonary vasculature. This review discusses specific features of scleroderma-related PAH, currently available and US FDA-approved therapy for this syndrome, as well as potential future therapeutic developments based on newly acquired knowledge of this disorder.
Paul M Hassoun
Related Documents :
10553928 - Low dose synthetic human atrial natriuretic peptide infusion in a patient with mitral s...
18846988 - Myocardial infarction in a 30-year-old patient with pheochromocytoma and type 1 neurofi...
9719018 - Systemic hypertension and coronary artery disease.
12441898 - Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: rep...
1929898 - Ultrasound findings in spontaneous carotid artery dissection. the value of duplex sonog...
14618658 - Jugular vein and carotid artery blood flow in fetuses with increased nuchal translucenc...
Publication Detail:
Journal Detail:
Title:  Expert review of respiratory medicine     Volume:  3     ISSN:  1747-6348     ISO Abbreviation:  Expert Rev Respir Med     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278196     Medline TA:  Expert Rev Respir Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  187-196     Citation Subset:  -    
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD 21224, USA, Tel.: +1 410 614 5158, ,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Grant Support
P50 HL084946-01//NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetics of green tea catechins in extract and sustained-release preparations.
Next Document:  Measurement of Cysteine Dioxygenase Activity and Protein Abundance.